Entry |
|
Name |
Eltanexor (USAN/INN) |
Formula |
C17H10F6N6O
|
Exact mass |
428.0820
|
Mol weight |
428.29
|
Structure |

|
Efficacy |
Antineoplastic, Nuclear export inhibitor |
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Transporters
Other transporters
Channels and pores (TC:1)
XPO1
D11499 Eltanexor (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 30
1 C8x C 12.9501 -15.3301
2 C8y C 12.9501 -16.7301
3 C8x C 14.1401 -17.4301
4 C8y C 15.4001 -16.7301
5 C8x C 15.4001 -15.3301
6 C8y C 14.1401 -14.6301
7 C1d C 14.1401 -13.2301
8 X F 12.7401 -13.2301
9 X F 15.5401 -13.2301
10 X F 14.1401 -11.8301
11 C1d C 11.7601 -17.4301
12 X F 11.0601 -16.2401
13 X F 12.4601 -18.6902
14 X F 10.5001 -18.1302
15 C8y C 16.5901 -17.4301
16 N5x N 16.5901 -18.8302
17 N4y N 17.9902 -19.2502
18 C8x C 18.7602 -18.1302
19 N5x N 17.9202 -17.0101
20 C2b C 18.4102 -20.5802
21 C2c C 19.8102 -20.5802
22 C5a C 20.5051 -21.7952
23 N1a N 21.9097 -21.8010
24 O5a O 19.8123 -22.9837
25 C8y C 20.5127 -19.3691
26 C8x C 21.9099 -19.3720
27 N5x N 22.6124 -18.1610
28 C8x C 21.9149 -16.9471
29 N5x N 20.5177 -16.9443
30 C8x C 19.8152 -18.1553
BOND 32
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 7 8 1
9 7 9 1
10 7 10 1
11 2 11 1
12 11 12 1
13 11 13 1
14 11 14 1
15 4 15 1
16 15 16 2
17 16 17 1
18 17 18 1
19 18 19 2
20 15 19 1
21 17 20 1
22 20 21 2
23 21 22 1
24 22 23 1
25 22 24 2
26 21 25 1
27 25 26 2
28 26 27 1
29 27 28 2
30 28 29 1
31 29 30 2
32 25 30 1
|